DETAILS, FICTION AND SITUS JUDI MBL77

Not all patients with CLL call for therapy. Irrespective of all latest improvements, the iwCLL still suggests watchful observation for patients with asymptomatic ailment.86 This advice is based on at the very least two randomized trials comparing observation to both chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,1